Rapamycin and Infection-related Illness
Running, not enrolling
Conditions studied: Infectious Diseases
In brief
Conduct a 6-month observational pilot clinical trial to evaluate the safety, monitor the adverse reactions and observe the preliminary effectiveness of medical treatment with oral rapamycin \[Rapamune (Sirolimus)\] in a total of 15 adults, 18 years and older toward preventing and lowering the severity of infectious disease or infection-related illness. Rapamune (Sirolimus) is not approved by the United States Food and Drug Administration (FDA) to prevent and lessen the severity of infection-related illness or infectious disease. Rapamune (Sirolimus) is approved by the FDA for other indications. The main procedures in the study include: * Blood tests to examine cholesterol, lipids, blood platelet counts, inflammation and infection-related health parameters * Questionnaires to examine brain function, mental health, symptoms, overall health status and quality of life * Electrocardiogram (ECG to measure heart function) * Resting diastolic and systolic blood pressure
Key facts
- Study ID
- NCT07054320
- Run by
- Hoskinson Health and Wellness Clinic
- People needed
- 15
- Starts
- 2025-08-06
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or Female Adults, 18 years and older
- Females of child-bearing age taking birth control medication
- Received a Hoskinson Health and Wellness Clinic physician prescription for Rapamune (Sirolimus)
You may not qualify if…
- Adults requiring monoclonal antibody or biological treatment
- Adults diagnosed with an acute lower respiratory or GI infection within 2 weeks
- Adults females who are not taking birth control medication, are pregnant or nursing mothers
- Adults reporting severe mental or physical disability
- Adults reporting unwillingness to travel to onsite clinical facilities
- Adults with any change in chronic disease symptoms or medication within 3 months
- Any contraindications to medical treatment with Rapamune (Sirolimus), as outlined in the FDA-approved medication guide
Where it is running
- Hoskinson Health and Wellness Clinic — Gillette, Wyoming, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.